103 related articles for article (PubMed ID: 6174492)
1. Bleomycin, cyclophosphamide and radiotherapy in regionally advanced epidermoid carcinoma of the head and neck.
Seagren SL; Byfield JE; Davidson TM; Sharp TR
Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):127-32. PubMed ID: 6174492
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for head and neck cancer relapsing after radiotherapy.
Cortes EP; Kalra J; Amin VC; Attie J; Eisenbud L; Khafif R; Wolk D; Aral I; Sciubba J; Akbiyik N; Heller K
Cancer; 1981 Apr; 47(8):1966-70. PubMed ID: 6164476
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with vinblastine, bleomycin, and cis-diamminedichloroplatinum (II) in squamous cell carcinoma of the head and neck.
Brown AW; Blom J; Butler WM; Garcia-Guerrero G; Richardson MF; Henderson RL
Cancer; 1980 Jun; 45(11):2830-5. PubMed ID: 6155199
[TBL] [Abstract][Full Text] [Related]
4. [Experiences with simultaneous cytostatic and radiotherapy treatment of advanced cancer of the head and neck].
Ehr R; Richter E
Laryngorhinootologie; 1990 Jun; 69(6):312-5. PubMed ID: 2378657
[TBL] [Abstract][Full Text] [Related]
5. A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer.
Vogl SE; Schoenfeld DA; Kaplan BH; Lerner HJ; Engstrom PF; Horton J
Cancer; 1985 Aug; 56(3):432-42. PubMed ID: 2408735
[TBL] [Abstract][Full Text] [Related]
6. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.
Suntharalingam M; Haas ML; Conley BA; Egorin MJ; Levy S; Sivasailam S; Herman JM; Jacobs MC; Gray WC; Ord RA; Aisner JA; Van Echo DA
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):49-56. PubMed ID: 10758304
[TBL] [Abstract][Full Text] [Related]
7. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
[TBL] [Abstract][Full Text] [Related]
8. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
[TBL] [Abstract][Full Text] [Related]
9. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of head and neck cancer: combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin.
Wittes RE; Spiro RH; Shah J; Gerold FP; Koven B; Strong EW
Med Pediatr Oncol; 1977; 3(3):301-9. PubMed ID: 85249
[TBL] [Abstract][Full Text] [Related]
11. Bleomycin infusion followed by cyclophosphamide, methotrexate, and 5-fluorouracil in advanced squamous carcinoma of the head and neck.
Plasse TF; Ohnuma T; Brooks S; Saponaro E; Holland JF; Biller H
Cancer; 1984 Feb; 53(4):841-3. PubMed ID: 6198061
[TBL] [Abstract][Full Text] [Related]
12. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy or chemotherapy and radiotherapy in advanced head and neck tumors. A prospective, randomized study comparing the 2 therapeutic modalities].
Klima A; von Ilberg C; Bergmann L; Zoubek A; Klippstein T; Mitrou PS; Szepesi S
HNO; 1987 Feb; 35(2):78-83. PubMed ID: 2437086
[TBL] [Abstract][Full Text] [Related]
14. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
[TBL] [Abstract][Full Text] [Related]
15. Combined radiotherapy and multidrug chemotherapy for advanced head and neck cancer: results of a Radiation Therapy Oncology Group pilot study.
Fu KK; Silverberg IJ; Phillips TL; Friedman MA
Cancer Treat Rep; 1979 Mar; 63(3):351-7. PubMed ID: 85493
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemotherapy and radiation therapy of selected head and neck squamous cell carcinomas using bleomycin and hydroxyurea: A Southwest Oncology Group Study.
Cruz AB; Perkins M; Aust JB; Coltman CA; Pollard EB; Fletcher WS; Kennedy P; Lehane DE; Mira J; McCracken JD; Sorgen SD; Page CP; Pendleton OJ; Reddy E; Sapp J; Smith F
J Surg Oncol; 1982 Aug; 20(4):233-7. PubMed ID: 6180251
[No Abstract] [Full Text] [Related]
17. Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer--preliminary report.
Smid L; Lesnicar H; Zakotnik B; Soba E; Budihna M; Furlan L; Zargi M; Rudolf Z
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):769-75. PubMed ID: 7540606
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
[TBL] [Abstract][Full Text] [Related]
19. Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer.
Haines I; Bosl G; Pfister D; Spiro R; Gerold F; Sessions R; Shah J; Strong E; Vikram B; Harrison L
J Clin Oncol; 1987 Oct; 5(10):1594-600. PubMed ID: 2443621
[TBL] [Abstract][Full Text] [Related]
20. [Initial polychemotherapy in the treatment of cancers of the head and neck. The efficacy and tolerance of 2 nonrandomized combinations in 48 patients].
Brun B; Mazeron JJ; Martin M; Lelièvre G; Langlois A; Feuillade F; Lebourgeois JP; Peynegre R; Grellet M; Pierquin B
Bull Cancer; 1984; 71(1):30-4. PubMed ID: 6201214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
